Source: Business Standard

Marksans Pharma: Marksans Pharma rises after receiving regulatory nod for supplying pharma products to Australia

Marksans Pharma added 2.22% to Rs 207.35 after the company announced that its Goa-based manufacturing facility has been approved by Australian TGA for manufacture of pharmaceutical formulations for Australian markets.

Read full article »
Marksans Pharma's Competitors | Marksans Pharma's News | Marksans Pharma's Financials
Stay up-to-date with the latest news on Marksans Pharma
Annual Revenue
$100-500M
Employees
500-1.0K
Mark Saldanha's photo - Managing Director of Marksans Pharma

Managing Director

Mark Saldanha

CEO Approval Rating

86/100

Read more
Stay up-to-date with the latest news on Marksans Pharma